Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Young’s expects full-year performance to beat market expectations after strong first half trading

Young’s expects full-year performance to beat market expectations after strong first half trading

BitgetBitget2026/09/30 06:03
  • Young & Co.'s Brewery expects full-year trading to beat current market expectations, citing a strong first-half performance.
  • Total revenue rose 10.4% in the 26 weeks ended Sept. 28, 2026; like-for-like sales increased 6.4%.
  • Like-for-like sales gained 7.9% in the last 13 weeks; garden or riverside sites posted 7.5% like-for-like growth.
  • Integration of the Cubitt House London pubs has been completed, contributing to performance; the group also bought back shares.
  • Young's moved from AIM to the London Stock Exchange Main Market in April.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Young & Co.'s Brewery plc published the original content used to generate this news brief via Business Wire (Ref. ID: 202609300200BIZWIRE_UKPR_REG_20260929_BW637280) on September 30, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Why did the Reserve Bank of Australia raise interest rates two weeks ago? Meeting minutes reveal inflation risks have become a reality, and waiting would be too costly

The Reserve Bank of Australia acknowledges that the trade-off between inflation and full employment has worsened, but maintains that its goal is to return the Consumer Price Index (CPI) to the 2-3% target range.

智通财经•2026/10/13 02:41

Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results

Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.

智通财经•2026/10/13 01:56